Fluorescent chemosensors based on xanthenes

and related d

Fluorescent chemosensors based on xanthenes

and related derivatives for the Hg2+ ions detection have been increasing due to the low cost and high applicability in industrial and biological processes [11]. During recent Volasertib mw years, novel inorganic-rhodamine hybrid sensors have been published. The rhodamine derivatives have been immobilized into the different inorganic receptors. Huang et al. reported fluorescent gold nanoparticle sensors for detection of Hg2+ ions [12]. Since gold nanoparticles (AuNPs) are highly efficient fluorescence quenchers, the rhodamine derivative had to be released from the AuNPs to restore the rhodamine fluorescence. Lee et al. and Zhou’s group developed a covalently bonded mesoporous silica rhodamine derivative [13, 14]. Childress and co-workers reported dye-doped polymer nanoparticles that are able to detect mercury ions. The nanoparticles were prepared by precipitation of highly fluorescent conjugated polymers and doped with rhodamine derivatives [15]. Recently,

Wang and Gao designed a mercury sensor using β-NaYF4:Yb3+/Eu3+ nanorods as the excitation source and a rhodamine derivative as a probe [16]. In this proposal, our research group has designed a new functional rhodamine derivative (Rh-UTES) that acts as a receptor of heavy metal ions. The Rh-UTES derivative was covalently bonded to porous silicon microcavity (PSiMc) to develop a hybrid sensor. The main advantage of the proposed method is the simplicity of the system and the fact that the hybrid sensor should be easy to carry for field applications. The PSiMc has proven p53 activator to be a suitable material with

unique optical properties for Cyclooxygenase (COX) the development of this kind of fluorescent sensor [17]. Our previous approaches in this field have shown that the detection of fluorescent molecules is possible using the optical properties of specific PSi structure (mirror or microcavity) [18]. Increased excitation and enhanced emission, both driven by the efficient reflection of light and resonance effects within the PSi microcavities, allowed the enhancement of the fluorescent response of the Rh-UTES derivative even at low molecular concentration. Hence, the variation of this method was used here to produce detection of low concentrations of heavy metals by forming metallic complexes within the pores that turn on the luminescence emission. Methods Rhodamine base, ethylenediamine, m-xylenediisocyanate, 3-aminopropyltriethoxysilane (APTES), hydrochloric acid, hydrofluoric acid, nitric acid, sodium hydroxide, and mercury nitrate were purchased from Sigma-Aldrich (St. Louis, MO, USA). All solvents were analytical reagent grade and used as received. Instruments and spectroscopy measurements The reflectivity spectra were recorded in an Agilent Cary 60 SB-715992 clinical trial UV-Vis spectrophotometer (Agilent Technologies, Sta.

The aim of this study is to determine the genetic relatedness of

The aim of this study is to determine the genetic relatedness of WA CA-MRSA clones within MAPK inhibitor different MLST clonal clusters (CC) providing an insight into the frequency of S. aureus SCCmec acquisition within a region. The genetic profile of these clones may also offer an explanation why only a few WA CA-MRSA clones have successfully adapted to the community environment. Results The 83 unique PFGE strains isolated in Western Australia from 1989 to 2010 were nuc and mecA gene positive by PCR. The DNA microarray S. aureus species markers gapA (CH5424802 price glyceraldehyde 3-phosphate dehydrogenase)

and rrn STAU (S. aureus ribosomal marker) were detected in all strains. The array’s linear primer elongation method detected the katA (catalase A), coA (coagulase), nuc, spa (protein A) and sbi (IgG-binding protein) S. aureus species markers in 78 strains. These markers were either not detected or detected only by random amplification in five strains (WA8, WA47, WA72, WA76 and WA79). Forty six STs were identified by MLST. Using the MLST website’s eBURST V3 algorithm 45 STs were grouped into 18 CCs and two singletons (Figure 1). The CC for WA76 https://www.selleckchem.com/products/BIRB-796-(Doramapimod).html (ST1303) has not been determined. Figure 1 eBURST generated population snapshot of CA-MRSA clones isolated in Western Australia ()

http://​www.​mlst.​net/​. Each sequence types (STs) is represented by a black dot. The ancestral ST of a clonal complex is represented by a blue dot. The size of the dot reflects the number of WA CA-MRSA clones with this ST. STs that diverge at no more than one of the seven MLST loci belong to the same clonal complex. Double locus variants (DLVs) are included Ureohydrolase if the linking single locus variant (SLV) was present in the MLST database. SLVs and DLVs of a sequence type are represented by pink and blue line respectively. Purple lines represent overlapping pink and blue lines. Several SCCmec types and subtypes, novel SCCmecs, and composite SCCmecs were identified. Forty five

strains harbor SCCmec IVa-d [2B] (31 IVa, 2 IVb, 9 IVc, 3 IVd), 12 strains SCCmec V [5C2] and two strains SCCmec VIII [4A]. Two strains have non typeable SCCmec IV subtypes and four strains have a SCCmec element with a novel ccr gene complex including three with a class B mec gene complex and one with a class A mec complex. Eighteen strains harbor SCCmec elements with composite ccr gene complexes including 12 with SCCmec V [5C2&5] (5C2 plus ccrC1 allele 8), three with SCCmec IVa [2B]&5 (2B plus a type 5 ccr gene complex), one with V (5C2)&2 (5C2 plus a type 2 ccr gene complex) and two with V [5C2&5]&2 (a composite SCCmec V element plus a type 2 ccr gene complex). The MLST, spa type, agr type, capsule type, SCCmec, antibiogram, resistance genotype, lukF/S-PVL genes, enterotoxin genes and bacteriophage associated virulence genes of each unique PFGE strain are provided in Additional File 1.

Finally, we would like to discuss more about the influence of sur

Finally, we would like to discuss more about the influence of surface condition on the Q-factor. It is already well known that an oxide coating layer with high refractive index promotes an effective refractive index and light confinement which leads to low light loss and higher Q-factor [3, 16, 21]. For the tubular microcavity in our work, the most important loss terms are bulk adsorption (Q mat -1) and loss introduced by surfaced Bioactive Compound Library contaminants (Q cont -1): Q -1 = Q mat -1 + Q cont -1[5, 18]. The adsorption of water molecules on the surface will increase the roughness of the tube wall as one kind of contaminant which magnifies Q cont -1 and consequently deteriorates the entire Q-factor. The desorption

of water molecules, on the contrary, will enhance the Q-factor. Both the water molecule

desorption and the increase of the tube wall thickness during ALD contribute to the enhancement of the Q-factor, as shown in Figure  2b. Conclusions In find more summary, we have demonstrated that physisorption and chemisorption of water can influence the optical resonance in rolled-up Y2O3/ZrO2 tubular microcavity. Desorption of these two kinds of water molecules from the surface of the tube wall at high temperature can cause a blueshift of optical modes while additional coating of oxide layers with high refractive index leads to a redshift of the modes. Although both effects promote the Q-factor of the microcavity, the competition among them produces a bi-directional shift of the modes during the ALD process. Our current work demonstrates the feasibility of precisely modulating the modes of the rolled-up microcavity with a fine structure and high Q-factor. These discoveries may find potential applications in environmental monitoring. For instance, a humidity sensor using a tubular microcavity as a core component can be fabricated to detect the humidity variation

of the environment. Acknowledgements This work is supported by the Methamphetamine Natural Science Foundation of China (nos. 51322201 and 51102049), ‘Shu Guang’ Rigosertib order project by Shanghai Municipal Education Commission and Shanghai Education Development Foundation, Project Based Personnel Exchange Program with CSC and DAAD, Specialized Research Fund for the Doctoral Program of Higher Education (no. 20120071110025), and Science and Technology Commission of Shanghai Municipality (nos. 12520706300 and 12PJ1400500). JW thanks the support from China Postdoctoral Science Foundation (no. 2011 M500731). We thank Dr. Zhenghua An from Fudan Nano-fabrication and Devices Laboratory for the assistance in sample fabrications. References 1. Gerard JM, Barrier D, Marzin JY, Kuszelewicz R, Manin L, Costard E, Thierry-Mieg V, Rivera T: Quantum boxes as active probes for photonic microstructures: the pillar microcavity case. Appl Phys Lett 1996, 69:449.CrossRef 2.

Cell viability assays Cell viability was determined using an MTT

Cell viability assays Cell viability was determined using an MTT assay according to the manufacturer’s

protocol. pcDNA™6.2-GW/EmGFP-miR RG-7388 in vivo (mock) and anti-miR-inhibitors-Negative control (control) were used as the controls for miR-302b and anti-miR-302b, respectively. The absorbance of each well was measured using a multidetection microplate reader (BMG LABTECH, Durham, NC, USA) at a wavelength of 570 nm. All experiments were performed in quadruplicate. Cell apoptosis assays Cells were washed with PBS and resuspended in 500 μL binding buffer containing 2.5 μL annexin V-phycoerythrin (PE) and 5 μL 7-amino-actinomycin D (7-AAD) to determine the phosphatidylserine (PS) exposure on the outer plasma membrane. After incubation, the samples were MK5108 chemical structure analyzed using flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA). The experiment was repeated three times. Cell invasion assay Cell selleck compound invasion was measured using transwell chambers (Millipore,

Billerica, USA) coated with Matrigel. After transfection, the harvested cells were suspended in serum free RPMI 1640 and were added into the upper compartment of the chamber; conditioned RPMI 1640 medium with 20% (v/v) FBS was used as a chemoattractant and placed in the bottom compartment of the chamber. After incubation, the cells were removed from the upper surface of the filter with a cotton swab. The invaded cells were then fixed and stained using 0.1% crystal violet. The cells were quantified from five different fields under a light microscope. The experiment was repeated in triplicate. Statistical analysis To investigate the association of miR-302b expression with clinicopathological features and survival, miR-302b expression values were separated into low and high expression groups using the median expression value within the cohort as a cutoff. A Fisher’s exact

text was used to analyze the relationship between miR-302b and the various clinicopathological characteristics. Progression-free survival (PFS) was defined as the time from the first day of treatment to the time of disease progression. The survival curves were built according to the Kaplan-Meier method, and the resulting curves were compared using the log-rank test. The joint effect of covariables was examined using the Cox proportional hazard regression model. For other analyses, PAK6 the data are expressed as the mean ± standard deviation. Differences between groups were assessed using an unpaired, two-tailed Student’s t test; P < 0.05 was considered significant. Results Expression of miR-302b in ESCC and its significance We examined the expression of miR-302b in a set of 50 paired samples using qRT-PCR. The results showed that miR-302b was significantly down-regulated in ESCC tissues when compared to the NAT (20 ± 3.42 vs 40 ± 5.24, P < 0.05, Figure 1A). Next, the correlation of miR-302b with the clinicopathological factors was examined.

However, up to now data assessing sensitivity and specificity of

However, up to now data assessing sensitivity and specificity of specific mutations for the detection of drug resistance phenotypes in our settings is still unavailable. Therefore CANTAM (Central Africa Network for Tuberculosis, HIV/AIDS and Malaria) an EDCTP (European and Developing Clinical BMS345541 mouse Trials Partnership) funded network [19], with the goal to establish a cohort and prepare new sites for conducting future clinical trials of new TB drugs and vaccines in Central Africa countries, carried out a population based study, involving MTBC

strains from Central region of Cameroon, to determine the genetic basis of first line drug resistance. Methods Mycobacterial isolates During this baseline study carried out between April 2010 and March 2011, 725 smear positive pulmonary tuberculosis patients were enrolled at Jamot Hospital and Mbalmayo District Hospital. All positive cultures were tested for drug susceptibility to INH (0.2 μg/ml and 1 μg/ml), SU5402 mouse RIF (40 μg/ml), EMB (2 μg/ml),

SM (4 μg/ml), OFX (2 μg/ml) and KAN (20 μg/ml) by the indirect proportion method on Lowenstein Jensen medium [20]. Phenotypically, 44 isolates were INHR (24 high level and 20 low level), 27 isolates were SMR, 7 isolates were RIFR and 2 isolates were EMBR. The 63 resistant isolates to INH, RIF, SM and EMB or MDR were screened for genetic mutations. In addition, M. tuberculosis strain H37Rv (susceptible) and 100 fully susceptible clinical isolates from the panel of susceptible strains collected during the study period were included to serve as controls. The study was approved by the Cameroon National Ethic Committee and the Cameroonian Ministry of Public Health. Written informed consent was obtained from all

study subjects. DNA extraction Briefly, a loop-full of mycobacterial Astemizole colonies was suspended in 400 μl of 10 mM Tris–HCl, 1 mM EDTA (pH 7.0) buffer and inactivated at 90°C for 30 min. The suspension was then centrifuged at 12,000 g for 1 min and the supernatant, containing nucleic acids, was harvested and transferred into a new eppendorf tube. Crude DNA extracts were stored at -20°C and then shipped to Germany for molecular analysis according to International Air Transport KU-57788 concentration Association guidelines. PCR amplification of target genes The DNA extract was used as a template for PCR with the primers listed in Table 1. Each final PCR volume of 20 μl contained 10× PCR buffer (Qiagen, Germany), 5% DMSO, 20 pmol of forward and 20 pmol of reverse primers, 11.9 μl of distilled water, 0.5 μl MgCl2 25 mM (Qiagen, Germany), dNTPs at a final concentration of 500 μM, 0.2 μl of Taq polymerase 5 U/μL (Qiagen, Germany), and 2 μl of crude DNA extract (≈50 ng). The cycling program included a cycle of an initial denaturation step at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 1 min, annealing at the temperature and time indicated in Table 1, and elongation at 72°C for 1 min. The final elongation step was set at 72°C for 10 min for one cycle.

In this context, we decided to conduct a two-step EQA study invol

In this context, we decided to conduct a two-step EQA study involving 16 pathology laboratories in the Lazio Region in Italy in order to evaluate their performance related to both the staining (step1) and the interpretation (step2) of IHC HER2 assay. The overall purpose of the study is to provide shared solutions to the common problems that may routinely occur during the biomarker determination process. The present paper reports the results of

this regional EQA program. Methods Study design The management activities of this EQA program were assigned to different working units: the Coordinating Center (CC), the Revising Centers (RCs) and the Participating Centers (PCs). The CC,

that coordinated the logistical and practical aspects P5091 cost of the EQA, collected a series of HER2 positive and negative BC cases from its own archive. A group of three reviewers (RCs), chosen based on their expertise in terms of the high number of HER2 tests per year, together with a pathologist of the CC, contributed in selecting the BC slides to be included in the EQA and in defining the HER2 IHC score to be used as reference value. In a detailed protocol, written before the start of the program, the aim of the study, the study design, the criteria for the selection of the cases, the HER2 evaluation procedure according to the ASCO-CAP this website guidelines [7] and the statistical analysis strategy were described. All 16 pathology laboratories SAR302503 in vivo that agreed to participate in the study accepted the protocol and filled out a questionnaire before the start of the study in order to gather information regarding their routine methods in the HER2 determination. The primary aim of this EQA consisted in evaluating the performance of each participant in relation to the whole process of HER2 Monoiodotyrosine determination. For this purpose, the EQA

program was implemented via two specific steps: EQA HER2 immunostaining and EQA HER2 interpretation. In the EQA HER2 immunostaining step, 64 BC cases were selected and each PC received 4 different BC sections. The PCs stained the slides by adopting their own procedures that were previously reported in the questionnaire and then sent them back to the CC (Figure 1A). The interpretation of all the 64 slides was performed by the group of RCs. For the EQA HER2 interpretation step, the 16 PCs were randomly divided into three groups. A set of 10 slides, for a total of 30 different BC cases, rotated among the participants belonging to each group (Figure 1B). Each set was generated in such a way as to fully cover the range of HER2 values usually observed in routine practice in order to include an adequate number of slides with intermediate scores (1+; 2+).

J Exp Med 205:1261–1268PubMedCrossRef

J Exp Med 205:1261–1268PubMedCrossRef NVP-HSP990 manufacturer 12. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, Laoutaris N, Karlsson K, Baran-Marzsak F, Tsaftaris A, Moreno C, Anagnostopoulos A, Caligaris-Cappio F, Vaur D, Ouzounis C, Belessi C, Ghia P, Davi F, Rosenquist R, Stamatopoulos K (2008) Stereotyped patterns of somatic AZD9291 ic50 hypermutation in subsets of patients with chronic lymphocytic leukemia: implications

for the role of antigen selection in leukemogenesis. Blood 111:1524–1533PubMedCrossRef 13. Li Y, Lu J, Prochownik EV (2009) Modularity of the oncoprotein-like properties of platelet glycoprotein Ibalpha. J Biol Chem 284:1410–1418PubMedCrossRef 14. Potapov AP, Voss N, Sasse N, Wingender E (2005) Topology of mammalian transcription networks. Genome Inform 16:270–278PubMed 15. Basak S, Hoffmann A (2008) Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 19:187–197PubMedCrossRef 16. De Bosscher K, Vanden Berglu W, Haegeman G (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25:6868–6886PubMedCrossRef 17. Kim D, Kolch W, Cho KH (2009) Multiple roles of the NF-kappaB signaling pathway regulated by coupled negative feedback

circuits. FASEB J, May 5, 23:1–7 18. Stelling J, Sauer U, Szallasi Z, Doyle FJ III, Doyle J (2004) Robustness of cellular functions. Cell NCT-501 molecular weight 118:675–685PubMedCrossRef 19. Pahler JC, Tazzyman S, Erez N, Chen YY, Murdoch C, Nozawa H, Lewis CE, Hanahan D (2008) Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 10:329–340PubMed 20. Meyer S, Vogt Clomifene T, Kunz-Schughart L, Bataille F, Reichle A, Hartmann A, Landthaler M, Sauter G, Wild PJ, Marx A, Andreesen R (2009) Cyclooxygenase2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) are stage-dependent prognostic markers of malignant melanoma. PPAR Res, in press 21. Reichle A, Vogt T, Coras B, Terheyden P, Neuber K, Trefzer U, Schultz E, Berand A, Brocker EB, Landthaler

M, Andreesen R (2007) Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res 17:360–364PubMedCrossRef 22. Le Bitoux MA, Stamenkovic I (2008) Tumor-host interactions: the role of inflammation. Histochem Cell Biol 130:1079–1090PubMedCrossRef 23. Kolch W (2008) Defining systems biology: through the eyes of a biochemist. IET Syst Biol 2:5–7PubMedCrossRef 24. Spemann H, Mangold H (2001) Induction of embryonic primordia by implantation of organizers from a different species. 1923. Int J Dev Biol 45:13–38PubMed 25. Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, PottiA FPG, West M, Nevins JR (2009) A genomic strategy to elucidate modules ofoncogenic pathway signature networks. Mol Cell 10:104–114CrossRef 26.

(http://​www ​ncbi ​nlm ​nih ​gov/​)

Strain typing The p

(http://​www.​ncbi.​nlm.​nih.​gov/​).

Strain typing The phylogenetic group of the ESBL-producing E. coli was determined by a multiplex PCR assay [18]. Isolates belonging to phylogenetic group B2 were screened with a Selleck Doramapimod previously established PCR-based method to identify the O25b subtype [19]. Furthermore, multilocus sequence typing (MLST) using the scheme of the Institut Pasteur, Paris, France (http://​www.​pasteur.​fr/​mlst) was used to confirm that CTX-M-15-producing E. coli O25b belonged to the international clone ST131 [19]. Genetic relatedness of the ESBL-producing strains was studied by PFGE following extraction of genomic DNA and digestion with XbaI PFGE according to a standard protocol using a GenePath system (Bio-Rad). PFGE banding profiles were compared digitally using Fingerprint II software (Bio-Rad) and relatedness was calculated using the unweighted pair group method with arithmetic KPT-330 ic50 mean (UPGMA) algorithm with similarity of bands using the Dice similarity indices. Isolates were considered to belong to the same PFGE cluster if their Dice similarity

index was >80% [20]. Transfer of ESBL resistance determinants and plasmid analysis Transfer of ESBL encoding genes by conjugation was performed by matting-out assays using E. coli J53-2 RifR or E. coli HB101 StrR as recipient strains. Transconjugants were selected Fedratinib molecular weight on MH agar containing rifampin (250 μg/mL) or streptomycin (50 μg/mL) plus ceftazidime or cefotaxime (2 μg/ml). When plasmids were not transferable by conjugation, a transformation experiment was assayed. Plasmid DNA obtained using the QIAprep Spin Miniprep kit (Qiagen) were electroporated into E. coli DH10B (Invitrogen). Transformants were selected on MH agar plates supplemented with ceftazidime (2 μg/mL) or cefotaxime (2 μg/mL). Plasmids were classified according to their incompatibility group using the PCR replicon-typing scheme described previously [21]. Detection of virulence factors and plasmid addiction systems For the ESBL-producing C-X-C chemokine receptor type 7 (CXCR-7) isolates, 17 virulence-associated genes were sought as previously described: fimH (type 1 fimbriae), papG (P fimbriae adhesion) alleles I, II and III, papC, sfa/focDE (S and F1C

fimbriae), afa/draBC (Dr-binding adhesions), iha (adhesion siderophore), hra (heat(resistant agglutinin), iutA (aerobactin receptor), fyuA (yersiniabcatin receptor), cnf-1 (cytotoxic necrotizing factor type 1), hlyA (α-hemolysin), sat (secreted autoreceptor toxin), kpsMT II (group II capsule), traT (serum resistance-associated) and pheR (phenylalanine tRNA, site of insertion from PAI V) [22]. For E. coli recipient strains, seven plasmid addiction system PemK–PemI (plasmid emergency maintenance), CcdA–CcdB (coupled cell division locus) RelB–RelE (relaxed control of stable RNA synthesis), ParD–ParE (DNA replication), VagC-VagD (virulence-associated protein), Hok–Sok (host-killing) and PndA–PndC (promotion of nucleic acid) were sought by PCR as described previously [7].

New York: McGraw-Hill; 1991:563–569 47 Boleij A, Schaeps RM, Tj

New York: McGraw-Hill; 1991:563–569. 47. Boleij A, Schaeps RM, Tjalsma H: Association between Streptococcus bovis and colon cancer. J Clin Microbiol 2009, 47:516.PubMedCrossRef 48. Lee RA, Woo PC, To AP, Lau SK, Wong SS, Yuen KY: Geographical difference of Tucidinostat purchase disease association in Streptococcus bovis bacteraemia. J Med Microbiol 2003, 52:903–908.PubMedCrossRef Selonsertib chemical structure 49. Luk WK, Liu CL, Yuen KY, Wong SS, Woo PC, Fan ST: Biliary tract infection due

to bile-soluble bacteria: an intriguing paradox. Clin Infect Dis 1998, 26:1010–1012.PubMedCrossRef 50. Vaska VL, Faoagali JL: Streptococcus bovis bacteraemia: identification within organism complex and association with endocarditis and colonic malignancy. Pathology 2009, 41:183–186.PubMedCrossRef 51. Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi D, Ruggiero G, Utili R: Streptococcus bovis endocarditis and its association with find more chronic liver disease: an underestimated risk factor. Clin Infect Dis 2004, 38:1394–1400.PubMedCrossRef 52. Osawa R, Sasaki E: Novel observations

of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus. J Clin Microbiol 2004, 42:4912–4913.PubMedCrossRef 53. Hsu WH, Yu FJ, Chuang CH, Chen CF, Lee CT, Lu CY: Occult colon cancer in a patient with diabetes and recurrent Klebsiella pneumoniae liver abscess. Kaohsiung J Med Sci 2009, 25:98–103.PubMedCrossRef 54. Hiraoka A, Yamashita Y, Uesugi K, Koizumi Y, Yamamoto Y, Doi H, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, et al.: Three cases of liver abscesses complicated with colon cancer without liver metastasis: importance of screening for digestive disease.

Intern Med 2007, 46:2013–2017.PubMedCrossRef 55. Pedrajas Ortiz A, Macias Mir P, Ruiz Serrato A, Garcia Ordonez MA: [Aortic endocarditis and spondylodiscitis due to Streptococcus bovis in a patient in his eighties with colon cancer.]. Rev Esp Geriatr Gerontol 2010,45(4):243–5.PubMedCrossRef 56. Vince KG, Kantor SR, Descalzi J: Late infection of HAS1 a total knee arthroplasty with Streptococcus bovis in association with carcinoma of the large intestine. J Arthroplasty 2003, 18:813–815.PubMedCrossRef 57. Gold JS, Bayar S, Salem RR: Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004, 139:760–765.PubMedCrossRef 58. Herrington CS, McGee JOD: Diagnostic molecular pathology: a practical approach. Oxford; New York: IRL Press at Oxford University Press; 1992. 59. Corredoira J, Alonso MP, Coira A, Varela J: Association between Streptococcus infantarius (formerly S. bovis II/1) bacteremia and noncolonic cancer. J Clin Microbiol 2008, 46:1570.PubMedCrossRef 60. Gelfand MS, Alford RH: Streptococcus bovis endocarditis and squamous-cell carcinoma of the mouth. N Engl J Med 1981, 305:284–285.PubMed 61. Anaf V, Noel JC, Thys JP, Simon P, Buxant F: A first case of Streptococcus bovis bacteremia and peritonitis from endometrial cancer origin.

The effect of the crystal plane orientation on the friction-induc

The effect of the crystal plane orientation on the friction-induced nanofabrication was mainly attributed to the different mechanical Apoptosis inhibitor behaviors and bond structures of the various silicon crystal planes. The main conclusions can be summarized as below. (1) Friction-induced nanofabrication can be realized on Si(100), Si(110), and Si(111) surfaces, respectively. The crystal plane orientation has a significant

effect on the hillock formation on silicon surface. Under the same loading condition, the highest hillock was generated on Si(100), while the lowest hillock was formed on Si(111) either in air or in vacuum.   (2) The mechanical performance of silicon shows a strong effect on the hillock formation on various silicon crystal planes. The crystal plane with the lower elastic modulus can lead to larger pressed volume, which facilitates more deformation in silicon matrix and higher hillock.   (3) The structures of Si-Si bonds play a key role in the hillock formation on various silicon

crystal planes. High density of dangling bonds can cause much instability, facilitating the formation of more amorphous silicon and high hillock during nanoscratching.   Acknowledgment The authors are grateful for the financial support from the National Basic Research Program (2011CB707604), Natural Science PI3K Inhibitor Library in vitro Foundation of China (90923017 and 51175441). References 1. Tanaka M: An industrial and applied review of new BCKDHB MEMS selleck products devices features. Microelectron Eng 2007, 84:1341–1344.CrossRef 2. Ko WH: Trends and frontiers of MEMS. Sens Actuators A 2007, 136:62–67.CrossRef 3. Cui Z: Micro-nanofabrication

Technologies and Applications. Beijing: Higher Education Press; 2008. 4. Lin BJ: Optical lithography – present and future challenges. Comptes Rendus Physique 2006,7(8):858–874.CrossRef 5. Cerofolini G (Ed): Nanoscale Devices: Fabrication, Functionalization, and Accessibility from the Macroscopic World. Heidelberg: Springer; 2009. 6. Pires D, Hedrick JL, Silva AD, Frommer J, Gotsmann B, Wolf H, Despont M, Duerig U, Knoll AW: Nanoscale three-dimensional patterning of molecular resists by scanning probes. Science 2010, 328:732–735.CrossRef 7. Yu BJ, Dong HS, Qian LM, Chen YF, Yu JX, Zhou ZR: Friction-induced nanofabrication on monocrystalline silicon. Nanotechnology 2009, 20:465303.CrossRef 8. Ebrahimi F, Kalwani L: Fracture anisotropy in silicon single crystal. Mater Sci Eng A 1999, 268:116–126.CrossRef 9. Wang MH, Wang W, Lu ZS: Anisotropy of machined surfaces involved in the ultra-precision turning of single-crystal silicon—a simulation and experimental study. Int J Adv Manuf Technol 2012, 60:473–485.CrossRef 10. Gatzen HH, Beck M: Investigations on the friction force anisotropy of the silicon lattice. Wear 2003, 254:1122–1126.CrossRef 11. Łysko JM: Anisotropic etching of the silicon crystal-surface free energy model. Mat Sci Semicon Proc 2003, 6:235–241.CrossRef 12.